Synthesis of Trimethyl Chitosan Nanoparticles Containing Recombinant BLF1-stxB Protein of Burkholderia Pseudomallei and Evaluation of its Immunogenicity in Mice
Open Access
- 1 February 2023
- journal article
- Published by CMV Verlag in Journal of Ilam University of Medical Sciences
- Vol. 30 (6), 61-72
- https://doi.org/10.52547/sjimu.30.6.61
Abstract
Introduction: The bacterium Burkholderia Pseudomallei is the cause of melioidosis disease. BLF1 plays an important role in the pathogenesis and infection of B. Pseudomallei. STxB has an adjuvant and carrier role and can be produced by mixing vaccine-candidate antigens with this adjuvant to produce a suitable vaccine. This study aimed to ...Keywords
This publication has 20 references indexed in Scilit:
- Protection by a Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Vaccine Expressing Shiga Toxin 2 B Subunit against Shiga Toxin-Producing Escherichia coli in MiceClinical and Vaccine Immunology, 2012
- A Burkholderia pseudomallei Toxin Inhibits Helicase Activity of Translation Factor eIF4AScience, 2011
- Identification of tomato plant as a novel host model for Burkholderia pseudomalleiBMC Microbiology, 2010
- A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2Vaccine, 2008
- Racing to Defuse a Bacterial Time BombScience, 2007
- Recombinant Shiga Toxin B-Subunit-Keyhole Limpet Hemocyanin Conjugate Vaccine Protects Mice from ShigatoxemiaInfection and Immunity, 2005
- Melioidosis: Epidemiology, Pathophysiology, and ManagementClinical Microbiology Reviews, 2005
- Shigella dysenteriaeSerotype 1, Kolkata, IndiaEmerging Infectious Diseases, 2003
- Public Health Assessment of Potential Biological Terrorism AgentsEmerging Infectious Diseases, 2002
- Value of Throat Swab in Diagnosis of MelioidosisJournal of Clinical Microbiology, 2001